HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ju Chen Selected Research

Wounds and Injuries (Trauma)

1/2017LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression.
1/2016Left- and right-sided video-assisted thoracoscopic thymectomy exhibit similar effects on myasthenia gravis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ju Chen Research Topics

Disease

21Neoplasms (Cancer)
03/2024 - 08/2009
20Cardiomyopathies (Cardiomyopathy)
01/2022 - 03/2002
13Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2022 - 03/2002
11Heart Failure
01/2020 - 03/2002
8Muscular Diseases (Myopathy)
05/2024 - 11/2007
8Heart Diseases (Heart Disease)
01/2023 - 04/2010
7Inflammation (Inflammations)
02/2023 - 01/2007
5Carcinogenesis
01/2022 - 04/2010
5Hypertrophy
10/2015 - 01/2004
5Fibrosis (Cirrhosis)
11/2014 - 03/2002
5Cardiomegaly (Heart Hypertrophy)
12/2013 - 01/2006
4Infections
02/2023 - 12/2013
4Body Weight (Weight, Body)
10/2016 - 01/2006
3Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
05/2024 - 01/2004
3Breast Neoplasms (Breast Cancer)
01/2020 - 05/2002
3Cardiac Arrhythmias (Arrythmia)
01/2020 - 02/2013
3Vascular Remodeling
01/2020 - 05/2012
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 03/2012
3Congenital Heart Defects (Congenital Heart Defect)
01/2018 - 04/2014
3Neoplasm Metastasis (Metastasis)
05/2016 - 05/2007
3Insulin Resistance
01/2015 - 01/2009
2Infarction (Infarctions)
10/2023 - 01/2018
2Hyperglycemia
01/2022 - 01/2020
2Hypertension (High Blood Pressure)
01/2022 - 05/2012
2Esophageal Squamous Cell Carcinoma
01/2020 - 01/2014
2Diabetes Mellitus
01/2020 - 01/2015
2Hypoxia (Hypoxemia)
01/2020 - 07/2008
2Vascular System Injuries
01/2020 - 11/2016
2Neointima
01/2020 - 11/2016
2Colorectal Neoplasms (Colorectal Cancer)
11/2019 - 01/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 05/2007
2Reperfusion Injury
12/2018 - 12/2013
2Glioblastoma (Glioblastoma Multiforme)
01/2018 - 01/2017
2Wounds and Injuries (Trauma)
01/2017 - 01/2016
2Ganglion Cysts (Ganglion)
04/2016 - 08/2007
2Glucose Intolerance
01/2015 - 01/2009
1Distal Myopathies (Distal Muscular Dystrophy)
05/2024
1Fever (Fevers)
09/2023
1Common Cold
09/2023
1Alzheimer Disease (Alzheimer's Disease)
02/2023
1Neuroinflammatory Diseases
02/2023
1Hematologic Neoplasms (Hematological Malignancy)
01/2023
1Cardiotoxicity
01/2023
1Heart Rupture
01/2023

Drug/Important Bio-Agent (IBA)

34Proteins (Proteins, Gene)FDA Link
03/2024 - 03/2002
5CytokinesIBA
02/2023 - 02/2013
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 08/2009
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 03/2002
5Cisplatin (Platino)FDA LinkGeneric
09/2021 - 03/2012
5Transcription Factors (Transcription Factor)IBA
01/2018 - 04/2014
5Protein Isoforms (Isoforms)IBA
11/2016 - 11/2007
5CalciumIBA
09/2015 - 01/2004
4MicroRNAs (MicroRNA)IBA
09/2021 - 03/2015
3Myosins (Myosin)IBA
05/2024 - 04/2012
3Interleukin-17 (Interleukin 17)IBA
01/2024 - 11/2019
3IntegrinsIBA
01/2023 - 03/2002
3Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2023 - 05/2009
3Phosphotransferases (Kinase)IBA
01/2020 - 05/2009
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2015
3neurofilament protein LIBA
02/2016 - 03/2012
3CalcineurinIBA
10/2015 - 05/2011
3DystrophinIBA
10/2015 - 01/2007
2Messenger RNA (mRNA)IBA
03/2024 - 01/2024
2thiazolyl blueIBA
04/2023 - 01/2023
2erythromycin propionate-N-acetylcysteinateIBA
01/2023 - 11/2016
2FilaminsIBA
01/2023 - 01/2022
2Calmodulin (Calcium-Dependent Activator Protein)IBA
01/2020 - 05/2009
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 01/2019
2Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2020 - 05/2009
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2020 - 01/2009
2Circular RNAIBA
01/2020 - 10/2017
2Leucine (L-Leucine)FDA Link
01/2019 - 03/2018
2Temozolomide (Temodar)FDA LinkGeneric
01/2018 - 05/2016
23- (5- tert- butylisoxazol- 3- yl)- 2- ((3- chlorophenyl)hydrazono)- 3- oxopropionitrileIBA
11/2016 - 11/2013
2Biomarkers (Surrogate Marker)IBA
02/2016 - 09/2014
2cysteine and glycine-rich protein 3IBA
01/2016 - 10/2015
2Cytoskeletal ProteinsIBA
10/2015 - 02/2009
2Peptide Hydrolases (Proteases)FDA Link
12/2013 - 01/2007
2Protein Kinase CIBA
05/2011 - 02/2004
2beta CateninIBA
04/2010 - 08/2008
2Focal Adhesion Protein-Tyrosine KinasesIBA
05/2008 - 01/2006
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
05/2024
1MYK-461IBA
05/2024
1Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2024
1CyclinsIBA
03/2024
1Interleukin-12 (IL 12)IBA
01/2024
1Immunologic Factors (Immunomodulators)IBA
01/2024
1E2F Transcription FactorsIBA
10/2023
1binafuxiIBA
09/2023
1AnthracyclinesIBA
01/2023
1atrophin-1IBA
01/2022
1IronIBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022

Therapy/Procedure

6Therapeutics
01/2024 - 01/2014
5Drug Therapy (Chemotherapy)
12/2022 - 03/2012
2Immunotherapy
01/2024 - 11/2019
2Radiotherapy
12/2022 - 01/2018
2Ligation
01/2020 - 11/2016
1Immunomodulation
01/2024
1Appendectomy
12/2022